LC vs TCRX · P/E 28, $1.43B cap vs rev $2.0M
LendingClub Corp (LC) versus Tscan Therapeutics Inc (TCRX) — a side-by-side from cached financials, not a winner call.
LendingClub Corp (LC) is a banks - regional company listed on US.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
LC does not have a complete income-statement cache yet.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
LC currently screens at market cap $1.43B and trailing P/E 28.4. TCRX currently screens at market cap $62.1M.
Not investment advice. Open the LC and TCRX stock pages for the full models.
Not investment advice.